MARSHALL WACE, LLP: CCS position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MARSHALL WACE, LLP on CCS, newest first. How the timeline and the estimate are built.
MARSHALL WACE, LLP held 61,916 CCS shares at 2026-06-30 per its 13F-HR filed 2026-08-13.
the latest 13F is the newest step
- period ended2026-06-3013F 61,916 sharesChange vs previous 13F -99,940 shares
<0.01% of the 13F portfolio, value $4,436,900.
13F-HR 0001318757-26-000010 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 161,856 sharesChange vs previous 13F -26,368 shares
0.01% of the 13F portfolio, value $9,287,295.
13F-HR 0001318757-26-000005 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 188,224 sharesChange vs previous 13F -140,546 shares
0.01% of the 13F portfolio, value $11,171,095.
13F-HR 0001318757-26-000003 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 328,770 sharesChange vs previous 13F +49,519 shares
0.02% of the 13F portfolio, value $20,834,154.
13F-HR 0001318757-25-000046 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 279,251 sharesChange vs previous 13F -18,043 shares
0.02% of the 13F portfolio, value $15,727,416.
13F-HR 0001318757-25-000034 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 297,294 sharesChange vs previous 13F +94,776 shares
0.03% of the 13F portfolio, value $19,948,427.
13F-HR 0001318757-25-000023 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 202,518 sharesChange vs previous 13F +175,887 shares
0.02% of the 13F portfolio, value $14,856,719.
13F-HR 0002048047-25-000005 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 26,631 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $2,742,460.
13F-HR 0001318757-24-000018 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).